Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Ezulix Software Private Limited

Ezulix Software is one of the leading website & mobile Game app development Company located in London, UK. provides custom software development services worldwide. 9+ Years Exp. 250+ Global Clients. 24/7 Support.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

Ezulix Software Private Limited
71-75 Shelton Street, London, United Kingdom
+447956982975
Contact Ezulix Software Private Limited
Website

 Latest Content from PMHub 

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Press Releases | November 27, 2025 | Cuttsy + Cuttsy

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

Does real-world use of AI in systematic literature reviews result in time and cost savings?

White Papers and Resources | November 27, 2025 | Amiculum

By Manca Povsic and Emma Griffiths

How DataGateway unified oncology data for real-world insights & market intelligence

White Papers and Resources | November 26, 2025 | Inizio

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Press Releases | November 26, 2025 | Inizio

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

White Papers and Resources | November 26, 2025 | Inizio

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?

White Papers and Resources | November 21, 2025 | Amiculum

By Emily Morton-West

The Future of MSL Training – How Digital Technologies Are Shaping Success

Press Releases | November 20, 2025 | Impetus Digital

Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.

Women Leaders Rewriting the Protocols of Rare Disease Care

Press Releases | November 20, 2025 | Medscape Education

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...

The Power of the Pivot: How Nurse Practitioners are Closing Care Gaps for Women

Press Releases | November 20, 2025 | Medscape Education

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a supervisory role. But for two pioneering NPs, Laura Demuth and Jackie...

Voices of Change: Women Leading the Menopause Movement

Press Releases | November 20, 2025 | Medscape Education

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as something women just had to “get past” and hardly worth...